caus
influenza
viru
influenza
flu
season
diseas
affec
million
peopl
world
everi
year
addit
influenza
viru
potenc
caus
sever
pandem
econom
loss
current
synthet
antivir
drug
vaccin
limit
use
develop
countri
due
emerg
resist
strain
high
cost
harm
side
effect
howev
antiinfluenza
compound
deriv
herb
mani
advantag
low
cost
low
toxic
extens
sourc
moreov
herbal
drug
usual
multitarget
effect
act
antivir
agent
also
stimul
immun
system
therefor
medicin
plant
extract
phytochem
attract
attent
potenti
sourc
develop
new
antivir
drug
recent
year
banlangen
radix
isatidi
dri
root
plant
isati
indigotica
fort
banlangen
radix
isatidi
firstli
document
herbal
medicin
divin
husbandman
herbal
foundat
canon
famou
ancient
medic
book
han
dynasti
china
ad
use
treatment
cold
sore
throat
headach
hundr
year
china
use
prevent
sever
acut
respiratori
syndrom
sar
swine
flu
pandem
china
japan
recent
antivir
effect
methanol
water
ethylacet
extract
banlangen
radix
isatidi
confirm
vitro
test
howev
mode
antivir
action
extract
still
clear
addit
public
report
differ
antivir
action
clemastanin
b
epigoitrin
extract
compound
isol
phenylpropanoid
pep
alkaloid
organ
acid
three
major
chemic
fraction
banlangen
radix
isatidi
clemastanin
b
cb
abund
compound
belong
phenylpropanoid
epigoitrin
main
alkaloid
compound
isol
banlangen
radix
isatidi
figur
latest
studi
show
clemastanin
b
inhibit
differ
subtyp
human
avian
influenza
virus
differ
magnitud
activ
epigoitrin
use
marker
antivir
efficaci
banlangen
radix
isatidi
edit
chines
pharmacopoeia
previou
screen
show
cb
epigoitrin
strong
inhibitori
effect
influenza
viru
present
studi
aim
investig
antiinfluenza
mechan
cb
epigoitrin
compar
phenylpropanoid
portion
mixtur
phenylpropanoid
alkaloid
organ
acid
fraction
pep
alk
oa
mous
lungadapt
variant
influenza
viru
strain
obtain
depart
microbiolog
immunolog
nanj
univers
chines
medicin
viru
propag
twice
allanto
caviti
embryon
hen
egg
h
enhanc
virul
allanto
fluid
harvest
measur
hemagglutin
activ
hemagglutin
titer
reach
viru
aliquot
store
use
madindarbi
canin
kidney
mdck
cell
human
cervic
cancer
hela
cell
obtain
institut
cell
biolog
chines
academi
scienc
posit
control
ribavirin
batch
purchas
baili
pharmaceut
co
ltd
sichuan
china
banlangen
radix
isatidi
collect
medic
market
tongl
citi
anhui
provinc
china
herb
identif
confirm
morpholog
microscop
analysi
accord
chines
pharmacopeia
clemastanin
b
epigoitrin
separ
purifi
laboratori
structur
figur
elucid
ultra
violet
uv
infrar
radiat
ir
mass
spectrometri
ms
hnuclear
magnet
reson
h
nmr
cnuclear
magnet
reson
c
nmr
dimension
nuclear
magnet
reson
nmr
data
puriti
two
compound
determin
hplcdadelsd
phenylpropanoid
alkaloid
organ
acid
fraction
prepar
use
previou
method
accord
yield
fraction
mixtur
phenylpropanoid
alkaloid
organ
acid
fraction
pep
alk
oa
prepar
mix
fraction
ratio
ww
lyophil
materi
directli
resuspend
cell
cultur
medium
filter
steril
membran
clemastanin
b
epigoitrin
dissolv
fresh
medium
dilut
differ
concentr
antiinfluenza
action
cb
epigoitrin
chemic
fraction
banlangen
radix
isatidi
extract
investig
four
differ
mode
therapeut
action
prophylaxi
direct
viru
inactiv
inhibit
viru
attach
cell
preinfect
viru
pure
compound
chemic
fraction
plant
extract
ad
therapeut
action
drug
evalu
cpe
reduct
assay
cell
mtt
assay
cpe
reduct
assay
conduct
previous
describ
modif
short
experiment
setup
consist
procedur
cpe
assay
day
incub
mtt
ad
well
incub
subsequ
dimethyl
sulfoxid
dmso
ad
absorb
measur
nm
cell
protect
rate
calcul
follow
formula
odexp
odviru
odcel
indic
absorb
test
sampl
viru
control
cell
control
respect
evalu
effect
pure
compound
chemic
fraction
woad
extract
prophylaxi
cell
infect
mdck
monolay
cell
plate
overlaid
differ
nontox
twofold
serial
dilut
two
bioactiv
compound
chemic
fraction
banlangen
radix
isatidi
extract
four
replic
set
treatment
control
h
test
substanc
remov
well
monolay
cell
infect
influenza
viru
h
allow
viru
absorpt
subsequ
unabsorb
viru
wash
use
pb
equal
amount
mainten
medium
ad
well
plate
incub
h
virusinduc
cpe
observ
light
microscop
grade
follow
criteria
describ
section
antivir
activ
preincub
direct
virucid
activ
pure
compound
chemic
fraction
woad
extract
test
accord
method
describ
carlucci
et
al
one
hundr
microlit
viru
treat
equal
volum
twofold
dilut
pure
compound
extract
fraction
h
sampl
tenfold
serial
dilut
confluent
monolay
mdck
cell
form
surviv
viru
mixtur
determin
cpe
assay
titer
valu
calcul
accord
reedmuench
method
mdck
cell
cultur
plate
one
hundr
microlit
differ
nontox
twofold
serial
dilut
pure
compound
chemic
fraction
banlangen
radix
isatidi
extract
equal
volum
viru
simultan
ad
mdck
cell
h
incub
viru
extract
mixtur
remov
well
disrupt
freez
thaw
twice
virusinduc
cpe
observ
light
microscop
grade
follow
criteria
describ
experi
repeat
three
time
quintupl
determin
data
express
mean
standard
deviat
x
analysi
varianc
duncan
multipl
rang
test
perform
test
signific
differ
differ
group
valu
p
consid
signific
differ
p
consid
signific
solvent
blank
cb
epigoitrin
chemic
fraction
banlangen
radix
isatidi
extract
obviou
cytotox
data
shown
therapeut
action
evalu
cpe
assay
mtt
assay
clear
cytopath
effect
observ
mdck
cell
infect
h
increas
gap
cell
ruptur
cell
nucleu
partial
complet
collaps
cell
figur
viru
control
viru
control
group
cpe
observ
tabl
howev
mdck
cell
grow
well
drug
treatment
group
figur
ribavirin
pep
alk
oa
portion
group
cpe
format
complet
inhibit
dilut
tabl
mtt
reduct
assay
show
addit
cb
epigoitrin
pep
pep
alk
oa
fraction
banlangen
radix
isatidi
extract
significantli
increas
viabil
mdck
cell
preinfect
viru
compar
viru
control
group
dilut
p
figur
interestingli
protect
rate
four
treatment
group
significantli
higher
posit
control
ribavirin
group
dilut
p
indic
compound
extract
fraction
banlangen
radix
isatidi
better
therapeut
action
influenza
viru
current
commerci
synthet
antivir
drug
ribavirin
addit
protect
effect
cb
epigoitrin
pep
pep
alkoa
fraction
dosedepend
highest
protect
rate
observ
dilut
cb
epigoitrin
mixtur
pep
alk
oa
fraction
pep
dilut
result
highest
cell
viabil
figur
comparison
differ
treatment
group
mixtur
pep
alk
oa
fraction
highest
cell
protect
rate
cpe
assay
show
obviou
cpe
format
mdck
cell
pretreat
cb
epigoitrin
pep
pep
alk
oa
fraction
dilut
tabl
shown
tabl
pretreat
either
pure
compound
chemic
fraction
banlangen
radix
isatidi
extract
dilut
significantli
improv
viabil
mdck
cell
p
moreov
compar
ribavirin
natur
compound
extract
banlangen
radix
isatidi
higher
prophylact
activ
influenza
viru
p
cell
viabil
dosedepend
increas
pep
pep
alk
oa
fraction
tabl
contrast
protect
rate
cell
viabil
significantli
chang
dilut
cb
epigoitrin
among
four
differ
samplesus
studi
pep
fraction
show
signific
protect
effect
cell
protect
rate
c
outcomesrev
cb
epigoitrin
pep
pep
alk
oa
could
directli
inactiv
influenza
viru
even
concentr
dilut
result
cpe
assay
list
tabl
cpe
format
drug
treatment
group
even
lowest
concentr
dilut
result
suggest
cb
epigoitrin
pep
pep
alk
oa
fraction
strong
inhibitori
effect
bind
influenza
viru
mdck
cell
viabil
mdck
cell
h
infect
viru
simultan
treatment
natur
compound
determin
mtt
reduct
assay
shown
tabl
viabil
mdck
cell
significantli
increas
result
drug
treatment
compar
viru
control
p
inhibit
viru
absorpt
host
cell
cb
epigoitrin
pep
dose
depend
manner
maximum
inhibitori
effect
cb
epigoitrin
pep
observ
dilut
result
time
increas
cell
viabil
respect
contrast
highest
cell
protect
rate
pep
alk
oa
posit
control
ribavirin
group
found
dilut
addit
show
cb
epigoitrin
pep
pep
alk
oa
effect
ribavirin
inhibit
influenza
viru
attach
tabl
compar
four
natur
compound
chemic
fraction
observ
pep
portion
dilut
possess
maximum
inhibitori
effect
viru
absorpt
led
highest
protect
classic
defin
antivir
mechan
medicin
plant
includ
inhibit
viru
replic
block
viru
attach
direct
inactiv
viru
prevent
viru
infect
studi
clearli
demonstr
cb
epigoitrin
pep
pep
alkoa
show
antiinfluenza
activ
therapeut
action
inhibit
viru
multipl
prophylaxsi
inhibit
viru
attach
howev
differ
observ
major
mode
antivir
action
differ
compound
chemic
fraction
figur
instanc
highest
cell
protect
rate
pep
pep
alk
oa
therapeut
action
figur
pep
pep
alk
oa
main
antiinfluenza
mode
epigoitrin
inhibit
viru
multipl
viru
attach
figur
epigoitrin
contrast
three
mode
antivir
action
cb
contribut
equal
cell
protect
rate
cb
major
phenylpropanoid
compound
banlangen
radix
isatidi
epigoitrin
abund
alkaloid
also
marker
qualiti
control
banlangen
radix
isatidi
previous
report
studi
point
overal
viru
inhibitori
effect
green
tea
stronger
plant
total
extract
singl
pure
compound
extract
due
possibl
synergist
interact
ingredi
howev
studi
result
show
antivir
activ
chang
might
result
differ
antivir
mechan
singl
compound
mixtur
extract
present
studi
result
suggest
cb
epigoitrin
pep
pepalkoa
demonstr
antiinfluenza
activ
therapeut
action
prophylaxsi
cell
inhibit
viru
attach
compound
chemic
fraction
direct
virucid
activ
main
antivir
mode
pep
pep
alk
oa
therapeut
action
epigoitrin
mainli
inhibit
viru
multipl
attach
studi
may
provid
theoret
basi
clarifi
antivir
mechan
banlangen
radix
isatidi
